Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Sorrento Therapeutics shares last traded at $0.00, with a volume of 49,255 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com assumed coverage on shares of Sorrento Therapeutics in a report on Tuesday. They issued a “hold” rating for the company.
Get Our Latest Research Report on Sorrento Therapeutics
Sorrento Therapeutics Stock Performance
About Sorrento Therapeutics
Sorrento Therapeutics, Inc, a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system.
Read More
- Five stocks we like better than Sorrento Therapeutics
- What Are Growth Stocks and Investing in Them
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Small Caps With Big Return Potential
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What Does a Stock Split Mean?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
